针对NAT10/XIST/YAP1轴介导的血管异常增强胃癌中的免疫检查点阻塞
Xuetao Lei1,2,3, Boyang Zheng1,4,2, Yanmei Peng5,6
1Department of General Surgery & Nanfang Gastrointestinal Cancer Institute (NGCI), Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P. R. China.
研究人员发现了一种涉及NAT10的新途径, 抑制这种途径使血管正常化并增强抗癌免疫反应,提高免疫疗法的有效性.
科学领域:
- 癌症学
- 分子生物学
- 免疫学
背景情况:
- 瘤血管正常化是一种改善抗癌免疫疗法的策略.
- 胃癌 (GC) 经常表现出异常的瘤血管,阻碍治疗的有效性.
研究的目的:
- 确定导致GC血管异常的新机制.
- 探索针对瘤血管和免疫微环境的治疗策略.
主要方法:
- 乙化RNA免疫沉测序的整合性分析 (acRIP-seq).
- 使用遗传和药物抑制的功能验证.
- 在综合性GC模型中评估瘤血管,免疫细胞透和抗瘤功效.
主要成果:
- 一个新的NAT10/XIST/YAP1/VEGFA信号轴被确定为GC血管异常的驱动因素.
- NAT10抑制稳定了瘤血管,并通过上调化学激素和促进细胞毒性淋巴细胞透来重塑免疫微环境.
- NAT10 抑制 (Remodelin) 和 YAP1 抑制 (Verteporfin) 的联合治疗协同增强了抗PD-1 疗效,抑制了瘤生长.
结论:
- 在GC中发现了一种依赖ac4C的表谱机制,调节血管-免疫交叉声.
- 提出针对NAT10和YAP1的新组合治疗策略,以克服GC免疫检查点阻塞的抵抗力.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
相关概念视频
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Cell Migration through Invadopodia
Regulation of Angiogenesis and Blood Supply
Tumor Immunotherapy
